EpiCept Corp. (EPCT) Granted Marketing Authorization for Leukemia Treatment in EU
EpiCept Corp. (Nasdaq: EPCT) focuses on advances in the treatment of cancer and pain. The company’s proprietary product, Ceplene, is…
EpiCept Corp. (Nasdaq: EPCT) focuses on advances in the treatment of cancer and pain. The company’s proprietary product, Ceplene, is…
Headquartered in Addison, Texas, Artfest International Inc. prints, markets, and sells limited edition, signed, and numbered fine art and collectibles.…
A.P. Pharma, Inc. (NASDAQ: APPA) is a specialty pharmaceutical company focused on the development and commercialization of innovative medical treatments…
A Yahoo! Finance article entitled "What's an Investor to Do Now?" gives some good advice on how the novice investor…
After weeks of deliberation as to the most prudent course of action regarding how to spend the $700 billion allocated…
Just one day after Russian authorities made the decision to halt trading on its stock exchages, Iceland followed suit. Officials…
North Bay Resources engages in the acquisition and development of mining properties for the extraction of a variety of precious…
Today, we are adding American Oriental Bioengineering Inc. to our China “One’s to Watch” list. Together with its subsidiaries, the…
China Yingxia International, Inc. (CYXI.OB), a China based health products developer, announced today a plan to repurchase up to $2…
As retail sales decline and homeowners/businesses put off purchases of updated computer hardware, age will slowly begin to creep into…